Live tape
Top 8, mentions 7d7,585META2,272 mentions▲ +0.06GOOGL1,514 mentions▲ +0.02NVDA813 mentions▲ +0.09MUSE667 mentions▲ +0.07MSFT611 mentions▲ +0.06SPY579 mentions▲ +0.05QQQ567 mentions▲ +0.08TSLA562 mentions▲ +0.06

Equity · Healthcare

CNTA

Centessa Pharmaceuticals plc · NGM

Price · Chart

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for CNTA to draw a line in its place.

The chart above plots the price of CNTA over the range selected — one day to the full history — drawn by TradingView from their own data.

CNTA insider trades

SEC Form 4

CNTA has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 24 June 2026.

Date Insider Type Shares Value
26 Mar 2026 Anderson Karen M. Chief People Officer Sell 41,076 $1.24M
26 Mar 2026 Weinhoff Gregory M Chief Business Officer Sell 23,998 $720K
17 Mar 2026 Anderson Karen M. Chief People Officer Sell 10,043 $282K
16 Mar 2026 Anderson Karen M. Chief People Officer Sell 64,768 $1.83M
13 Mar 2026 Anderson Karen M. Chief People Officer Sell 120,029 $3.15M
13 Mar 2026 Weinhoff Gregory M Chief Business Officer Sell 73,196 $1.93M
02 Feb 2026 HUSSAIN IQBAL J Chief Legal Officer Sell 38,951 $980K
30 Jan 2026 HUSSAIN IQBAL J Chief Legal Officer Sell 1,010 $25K
09 Dec 2025 Accardi Mario Alberto President, Orexin Program Sell 10,000 $288K
08 Dec 2025 Accardi Mario Alberto President, Orexin Program Sell 10,000 $300K
17 Nov 2025 Bush Tia L Chief Technology & Quality Ofc Sell 40,000 $1.12M
17 Nov 2025 HUSSAIN IQBAL J General Counsel Sell 6,000 $166K

Showing the 12 most recent of 23 open-market trades in this window. The figures above count all of them.

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
24 Jun 2026 Accardi Mario Alberto Chief Executive Officer Other 243,282
24 Jun 2026 Anderson Karen M. Chief People Officer Other 62,085
24 Jun 2026 Bush Tia L Chief Technology & Quality Ofc Other 147,954
24 Jun 2026 Weinhoff Gregory M Chief Business Officer Other 65,925
24 Jun 2026 GOYAL ARJUN Director Other 462,585
24 Jun 2026 De Rubertis Francesco Director Other 19,963,157
24 Jun 2026 Kanes Stephen Chief Medical Officer Other 120,000
24 Jun 2026 Deferiere Raphael Chief Accounting Officer Other 11,000
24 Jun 2026 Crowley John J Chief Financial Officer Other 45,000
24 Jun 2026 HUSSAIN IQBAL J Chief Legal Officer Other 123,145
01 May 2026 Accardi Mario Alberto Chief Executive Officer Tax withheld 604 $24K
26 Mar 2026 Anderson Karen M. Chief People Officer Option exercise 41,076 $329K

Showing the 12 most recent of 43 compensation filings in this window. The figures above count all of them.

CNTA earnings

SEC EDGAR
Date Period EPS Revenue
31 Mar 2026 Q1 2026 $-0.52 —
31 Dec 2025 FY 2025 $-1.46 $15M
30 Sep 2025 Q3 2025 $-0.41 —
30 Jun 2025 Q2 2025 $-0.38 —
31 Mar 2025 Q1 2025 $-0.20 $15M
31 Dec 2024 FY 2024 $-2.06 —
30 Sep 2024 Q3 2024 $-0.37 —
30 Jun 2024 Q2 2024 $-0.40 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

CNTA institutional holders

SEC Form 13F

0 of the 45 institutional funds we track reported a CNTA position for the quarter ended 30 Jun 2026; the latest of those filings landed 02 Sep 2026.

Source: SEC EDGAR 13F filings